For citations:
Abdulaeva R.Sh., Timofeeva E.Yu., Obarevich E.S., Gavrilova D.A., Besova N.S., Makiev G.G., Tryakin A.A., Evdokimov V.I., Pokataev I.A., Zhukova L.G., Danilova A.S., Fedyanin M.Yu., Cheporov S.V., Osipov M.A., Molodorina V.V. HER2-positive metastatic gastric / cardioesophageal junction cancer: a comparative retrospective analysis of trastuzumab maintenance therapy regimens. Medical alphabet. 2025;(33):7-12. (In Russ.) https://doi.org/10.33667/2078-5631-2025-33-7-12
JATS XML
Email this article 